Orca Bio

Associate Director, Regulatory Affairs Labeling, Advertising and Promotion

Remote

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

Candidates should possess a Bachelor's degree in a scientific discipline, such as Biology, Chemistry, or Pharmacy, and hold a Ph.D. in a related field or equivalent experience. Strong knowledge of US regulatory requirements for pharmaceutical advertising and promotion, including FDA guidelines and regulations, is essential. Experience in regulatory affairs within the biotechnology or pharmaceutical industry, particularly with cell therapies, is highly desired. Demonstrated ability to interpret and apply complex regulations to promotional materials is required.

Responsibilities

The Associate Director will define commercial regulatory strategies, ensuring all corporate communications adhere to regulatory standards. They will provide regulatory guidance on new marketing concepts and messaging, reviewing and approving all US promotional materials in collaboration with cross-functional teams. The role involves managing the strategy and operational aspects of regulatory labeling for Phase 3 and commercial assets, ensuring accuracy and compliance. Serving as a liaison with the FDA’s promotional review divisions and participating in application labeling negotiations is also a key responsibility. Furthermore, the individual will lead the strategy, coordination, and execution of post-approval regulatory submissions, such as phase 3b/4 studies and amendments, and maintain a strong understanding of FDA regulations and enforcement actions related to pharmaceutical advertising and promotion.

Skills

Regulatory Affairs
FDA regulations
pharmaceutical advertising
promotion review
regulatory strategy
post-approval submissions
cross-functional collaboration
regulatory guidance

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Key Metrics

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI